Ion channel inhibition against COVID-19: A novel target for clinical investigation.
Publication
, Journal Article
Navarese, EP; Musci, RL; Frediani, L; Gurbel, PA; Kubica, J
Published in: Cardiol J
2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Cardiol J
DOI
EISSN
1898-018X
Publication Date
2020
Volume
27
Issue
4
Start / End Page
421 / 424
Location
Poland
Related Subject Headings
- World Health Organization
- Viral Proteins
- Verapamil
- Severity of Illness Index
- Severe Acute Respiratory Syndrome
- Poland
- Pneumonia, Viral
- Pandemics
- Needs Assessment
- Male
Citation
APA
Chicago
ICMJE
MLA
NLM
Navarese, E. P., Musci, R. L., Frediani, L., Gurbel, P. A., & Kubica, J. (2020). Ion channel inhibition against COVID-19: A novel target for clinical investigation. Cardiol J, 27(4), 421–424. https://doi.org/10.5603/CJ.a2020.0090
Navarese, Eliano P., Rita L. Musci, Lara Frediani, Paul A. Gurbel, and Jacek Kubica. “Ion channel inhibition against COVID-19: A novel target for clinical investigation.” Cardiol J 27, no. 4 (2020): 421–24. https://doi.org/10.5603/CJ.a2020.0090.
Navarese EP, Musci RL, Frediani L, Gurbel PA, Kubica J. Ion channel inhibition against COVID-19: A novel target for clinical investigation. Cardiol J. 2020;27(4):421–4.
Navarese, Eliano P., et al. “Ion channel inhibition against COVID-19: A novel target for clinical investigation.” Cardiol J, vol. 27, no. 4, 2020, pp. 421–24. Pubmed, doi:10.5603/CJ.a2020.0090.
Navarese EP, Musci RL, Frediani L, Gurbel PA, Kubica J. Ion channel inhibition against COVID-19: A novel target for clinical investigation. Cardiol J. 2020;27(4):421–424.
Published In
Cardiol J
DOI
EISSN
1898-018X
Publication Date
2020
Volume
27
Issue
4
Start / End Page
421 / 424
Location
Poland
Related Subject Headings
- World Health Organization
- Viral Proteins
- Verapamil
- Severity of Illness Index
- Severe Acute Respiratory Syndrome
- Poland
- Pneumonia, Viral
- Pandemics
- Needs Assessment
- Male